Effect of Radiotherapy Interruptions on Survival in Medicare Enrollees With Local and Regional Head-and-Neck Cancer
- 1 November 2010
- journal article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 78 (3), 675-681
- https://doi.org/10.1016/j.ijrobp.2009.08.004
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Head and neck cancerThe Lancet, 2008
- Participation in Surgical Oncology Clinical Trials: Gender-, Race/Ethnicity-, and Age-based DisparitiesAnnals of Surgical Oncology, 2007
- Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysisThe Lancet, 2006
- Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma—the University of Iowa experienceInternational Journal of Radiation Oncology*Biology*Physics, 2005
- The treatment of early laryngeal cancers (T1–T2 N0): surgery or irradiation?Head & Neck, 2004
- Time factor in postoperative radiotherapy: A multivariate locoregional control analysis in 868 patientsInternational Journal of Radiation Oncology*Biology*Physics, 2003
- How fast is repopulation of tumor cells during the treatment gap?International Journal of Radiation Oncology*Biology*Physics, 2002
- Completion of Radiotherapy for Local and Regional Head and Neck Cancer in MedicareJAMA Otolaryngology–Head & Neck Surgery, 2002
- A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003International Journal of Radiation Oncology*Biology*Physics, 2000
- Does tumor control decrease by prolonging overall treatment time or interrupting treatment in laryngeal cancer?Radiotherapy and Oncology, 1995